Information about HepaVue Dx
My details
*
*
*

HepaVue Dx (SRL)

BE

0803.100.414

Company information

Status
Active

Enterprise number

BE0803.100.414

VAT liability
Yes
Established
23-06-2023
Last balance sheet year
2025
Company size
Medium-sized 1 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from HepaVue Dx

2025 2024
Income statement
Profit/Loss € -351,134 -736% € -42,023
Gross margin € -299,924 -625% € -41,383
Balance sheet
Balance sheet total € 3,710,704 466% € 655,488
Equity € 429,994 > 1000% € -22,023
Debts € 3,280,710 384% € 677,512
Other
Employees 1

Publications from HepaVue Dx

Date Publication
08-05-2025 Articles of Association (Translation, Coordination, Other Modifications, …) - Capital, Shares (FR)
04-03-2025 Registered Office (FR)
27-06-2023 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of HepaVue Dx?
The VAT number of HepaVue Dx is BE 0803.100.414.
Wat is the PEPPOL ID of HepaVue Dx?
The PEPPOL ID of HepaVue Dx is 0208:0803100414. Log in or start a free trial to see the full overview.
When was HepaVue Dx founded?
HepaVue Dx was founded on 23-06-2023.
What is the address of HepaVue Dx?
The current registered office of HepaVue Dx is located at Drève Richelle 161M/57, 1410 Waterloo.
When was the last time HepaVue Dx filed their annual financial statements?
The most recent financial statements of HepaVue Dx were filed on 26-08-2026.
How many employees does HepaVue Dx have?
There are 1 FTEs working at HepaVue Dx according to the staff figures in the most recent financial statements.
What is the annual turnover of HepaVue Dx?
At the time of its most recent financial statements, HepaVue Dx did not publish any turnover figures. HepaVue Dx reported a gross margin of -€299,923.66.

Sources